• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Taiwan·Consumer Cyclical·1736.TW
Share

Johnson Health Tech .Co., Ltd. Stocks

NT$ 129.5Last Updated 21.08.2026

Issuer Rating

5/7
Performance

Favourable

Risk

Limited

Recommendation

Hold

Market Cap

NT$ 1.29B

NT$ 129.5
Key Takeaways

Risk factor

Resilient to price shocks

Data is available to registered users only
Data is available to registered users only

Profitability factor

Favourable analyst view

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Johnson Health Tech. Co., Ltd. is a prominent global supplier specializing in the production and distribution of health and fitness equipment. Their diverse product lineup includes a wide array of cardiovascular and strength training machines, alongside integrated electronic components and a dedicated video streaming service. Operating worldwide, the company serves key markets across the Americas, Europe, and Asia, with a notable presence in China. Beyond their core fitness offerings, Johnson Health Tech also researches, develops, and markets therapeutic massage chairs, and provides a selection of food products. The enterprise was founded in 1975 and is headquartered in Taichung City, Taiwan.

Company Valuation

Fairly valued
4/7

Based on key historical and expected multiples, the stock is fairly valued relative to its peers. Specifically, the stock is fairly valued on P/E, neutral on EV/EBITDA, r

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Favourable
6/7

The average target price of 1736.TW is 195 and suggests 48.3% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to in

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

23.08.2026 21:01

Anthropic to Strengthen Founders' Rights and Unitree's 460% Surge: Key Takeaways on the IPO by August 23

23.08.2026 18:01

Investors' Magical Thinking: The Power of Rituals, Superstitions, and Luck in the Stock Market

23.08.2026 15:01

"Stop Drawing Colorful Charts": How to Make Plans in an Era of Change

22.08.2026 16:01

What's Happening in Small-Cap Stocks: Curaleaf's Offering, a New GLP-1 Drug, and a Defense IPO

22.08.2026 13:01

U.S. national debt weighs on the market; top model joins a Kazakhstani AI company; Nasdaq to open at night

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026